DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Dysbiosis D064806 2 associated lipids
Chronic Pain D059350 5 associated lipids
Peripheral Nerve Injuries D059348 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Geographic Atrophy D057092 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma D054218 5 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Minami M and Noguchi M Effects of low-dose eicosapentaenoic acid, docosahexaenoic acid and dietary fat on the incidence, growth and cell kinetics of mammary carcinomas in rats. 1996 Sep-Oct Oncology pmid:8784475
Noguchi M et al. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. 1995 Jul-Aug Oncology pmid:7777237
Li S et al. The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy. 2014 Oncotarget pmid:25004114
Lam SM et al. Biological relevance of fatty acyl heterogeneity to the neural membrane dynamics of rhesus macaques during normative aging. 2016 Oncotarget pmid:27517158
Ostroumova TV et al. [Docosahexaenoyl dopamine in freshwater hydra: effects on regeneration and metabolic changes]. 2010 May-Jun Ontogenez pmid:20583627
Nourooz-Zadeh J and Pereira P Age-related accumulation of free polyunsaturated fatty acids in human retina. 1999 Ophthalmic Res. pmid:10325542
Miyauchi O et al. Protective effect of docosahexaenoic acid against retinal ischemic injury: an electroretinographic study. 2001 Jul-Aug Ophthalmic Res. pmid:11464070
Simonelli F et al. Evaluation of fatty acids in membrane phospholipids of erythrocytes in retinitis pigmentosa patients. 1996 Ophthalmic Res. pmid:8792359
Moriguchi K et al. Suppression of N-methyl-N-nitrosourea-induced photoreceptor apoptosis in rats by docosahexaenoic acid. 2004 Mar-Apr Ophthalmic Res. pmid:15017106
Schnebelen C et al. Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. 2009 Ophthalmic Res. pmid:19451735
Poloschek CM and Jägle H [Pharmacological concepts to treat hereditary retinal degenerations]. 2012 Ophthalmologe pmid:22350547
Chew EY et al. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). 2012 Ophthalmology pmid:22840421
Chiu CJ et al. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. 2009 Ophthalmology pmid:19410952
Dangour AD et al. N-3 fatty acids and retinal function. 2013 Ophthalmology pmid:23714605
Kangari H et al. Short-term consumption of oral omega-3 and dry eye syndrome. 2013 Ophthalmology pmid:23642375
Souied EH et al. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. 2013 Ophthalmology pmid:23395546
Dagnelie G et al. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. 2000 Optometry pmid:10970259
Aursnes M et al. Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator. 2014 Org. Biomol. Chem. pmid:24253202
Varga Z [Omega-3 polyunsaturated fatty acids in the prevention of atherosclerosis]. 2008 Orv Hetil pmid:18375362
Fischer T [Pharmacological therapy of age-related macular degeneration based on etiopathogenesis]. 2015 Orv Hetil pmid:26548469
Marosvölgyi T et al. [Fatty acid composition of human milk in mothers of preterm and full-term infants in the first three weeks of lactation]. 2006 Orv Hetil pmid:16981419
Li R et al. Maresin 1, a Proresolving Lipid Mediator, Mitigates Carbon Tetrachloride-Induced Liver Injury in Mice. 2016 Oxid Med Cell Longev pmid:26881046
Zhang X et al. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. 2013 Oxid Med Cell Longev pmid:24381712
Sontrop J et al. Depressive symptoms during pregnancy in relation to fish consumption and intake of n-3 polyunsaturated fatty acids. 2008 Paediatr Perinat Epidemiol pmid:18578753
Huang L et al. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. 2011 Pain pmid:21255928
Lucena CF et al. Omega-3 supplementation improves pancreatic islet redox status: in vivo and in vitro studies. 2015 Pancreas pmid:25426612
Song KS et al. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. 2011 Pancreatology pmid:22213040
Kuchbaev AE and Bastarbekova GM [Phospholipid and fatty acid content of the blood of sheep infected with the nematode Dictyocaulus filaria]. 2001 Sep-Oct Parazitologia pmid:11871259
Weise C et al. Dietary polyunsaturated fatty acids and non-digestible oligosaccharides reduce dermatitis in mice. 2013 Pediatr Allergy Immunol pmid:23577592
Weise C et al. Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice. 2011 Pediatr Allergy Immunol pmid:21294775
Furuhjelm C et al. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. 2011 Pediatr Allergy Immunol pmid:21332799
Wang L et al. Comparison of the fatty acid composition of total lipids and phospholipids in breast milk from Japanese women. 2000 Pediatr Int pmid:10703228
Francescato G et al. Early retinol-binding protein levels are associated with growth changes in infants born to diabetic mothers. 2012 Pediatr Obes pmid:22991250
Galicia-Connolly EZ et al. Complementary, holistic, and integrative medicine: therapies for learning disabilities. 2011 Pediatr Rev pmid:21285298
Galicia-Connolly E et al. Complementary, holistic, and integrative medicine: therapies for neurodevelopment in preterm infants. 2012 Pediatr Rev pmid:22659260
Feucht C and Patel DR Herbal medicines in pediatric neuropsychiatry. 2011 Pediatr. Clin. North Am. pmid:21281847
Ahmad A et al. Decrease in neuron size in docosahexaenoic acid-deficient brain. 2002 Pediatr. Neurol. pmid:11955929
Kurlandsky LE et al. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. 1994 Pediatr. Pulmonol. pmid:7838619
Llanos A et al. Infants with intrauterine growth restriction have impaired formation of docosahexaenoic acid in early neonatal life: a stable isotope study. 2005 Pediatr. Res. pmid:16189202
Agostoni C and Verduci E DHA in pregnancy benefits child development. 2003 Pediatr. Res. pmid:12904586
Liu CC et al. Increase in plasma phospholipid docosahexaenoic and eicosapentaenoic acids as a reflection of their intake and mode of administration. 1987 Pediatr. Res. pmid:2821474
Woods J et al. Is docosahexaenoic acid necessary in infant formula? Evaluation of high linolenate diets in the neonatal rat. 1996 Pediatr. Res. pmid:8910933
Lauritzen L et al. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. 2005 Pediatr. Res. pmid:16006428
Ponder DL et al. Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil. 1992 Pediatr. Res. pmid:1287559
Curatolo N et al. Oral administration of docosahexaenoic acid/eicosapentaeinoic acids is not anticonvulsant in rats: implications for translational research. 2011 Pediatr. Res. pmid:21857379
Greiner RC et al. Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary alpha-linolenic and docosahexaenoic acids. 1997 Pediatr. Res. pmid:9396565
Salem N What is the right level of DHA in the infant diet? Commentary on article by Hsieh et al. on page 537. 2007 Pediatr. Res. pmid:17413853
Hsieh AT et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. 2007 Pediatr. Res. pmid:17413857
Lim SY et al. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. 2005 Pediatr. Res. pmid:16189203
Colombo J et al. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. 2011 Pediatr. Res. pmid:21705959
Farquharson J et al. Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy. 1995 Pediatr. Res. pmid:7494660
Sauerwald TU et al. Intermediates in endogenous synthesis of C22:6 omega 3 and C20:4 omega 6 by term and preterm infants. 1997 Pediatr. Res. pmid:9029636
García-Calatayud S et al. Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and supplementation limited to lactation. 2005 Pediatr. Res. pmid:15718358
Lefkowitz W et al. Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat. 2005 Pediatr. Res. pmid:15531740
Mollard RC and Weiler HA Dietary arachidonic acid and docosahexaenoic acid elevate femur calcium and reduce zinc content in piglets. 2006 Pediatr. Res. pmid:16940244
Su HM et al. Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. 1999 Pediatr. Res. pmid:9890614
Bouwstra H et al. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. 2006 Pediatr. Res. pmid:16857765
Damsgaard CT et al. The effects of n-3 long-chain polyunsaturated fatty acids on bone formation and growth factors in adolescent boys. 2012 Pediatr. Res. pmid:22337227
Anderson GJ et al. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. 1990 Pediatr. Res. pmid:2136947
Champoux M et al. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. 2002 Pediatr. Res. pmid:11861930
Lapillonne A et al. The use of low-EPA fish oil for long-chain polyunsaturated fatty acid supplementation of preterm infants. 2000 Pediatr. Res. pmid:11102555
Larqué E et al. Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats. 2000 Pediatr. Res. pmid:10674359
Bowen RA et al. Does increasing dietary linolenic acid content increase the docosahexaenoic acid content of phospholipids in neuronal cells of neonatal rats? 1999 Pediatr. Res. pmid:10367771
Sarkadi-Nagy E et al. The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues. 2003 Pediatr. Res. pmid:12736388
Makrides M et al. Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. 1993 Pediatr. Res. pmid:8479826
Birch EE et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. 1998 Pediatr. Res. pmid:9702915
Carlson SE et al. Effect of fish oil supplementation on the n-3 fatty acid content of red blood cell membranes in preterm infants. 1987 Pediatr. Res. pmid:2954026
Dunstan JA et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. 2007 Pediatr. Res. pmid:17957152
Carlson SE et al. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids. 1991 Pediatr. Res. pmid:1684416
Carlson SE et al. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. 1996 Pediatr. Res. pmid:8726246
Morris SA et al. Developmental sensitivity of the piglet brain to docosahexanoic acid. 1999 Pediatr. Res. pmid:10509359
Cetin I et al. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. 2002 Pediatr. Res. pmid:12409524
Clandinin MT et al. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. 1997 Pediatr. Res. pmid:9396564
Wijendran V et al. Long-chain polyunsaturated fatty acids attenuate the IL-1β-induced proinflammatory response in human fetal intestinal epithelial cells. 2015 Pediatr. Res. pmid:26270575
Groh-Wargo S et al. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial. 2005 Pediatr. Res. pmid:15718356
Mayes C et al. Variation in [U-13C] alpha linolenic acid absorption, beta-oxidation and conversion to docosahexaenoic acid in the pre-term infant fed a DHA-enriched formula. 2006 Pediatr. Res. pmid:16439591
de la Presa Owens S and Innis SM Diverse, region-specific effects of addition of arachidonic and docosahexanoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. 2000 Pediatr. Res. pmid:10879811
Carnielli VP et al. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. 1996 Pediatr. Res. pmid:8798265
Sweeney B et al. Polyunsaturated fatty acids influence neonatal monocyte survival. 2001 Pediatr. Surg. Int. pmid:11409157
Makrides M et al. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial. 2000 Pediatrics pmid:10617701
Scott DT et al. Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? 1998 Pediatrics pmid:9794989
Mizejewski GJ and Pass KA Fatty acids, alpha-fetoprotein, and cystic fibrosis. 2001 Pediatrics pmid:11731663
O'Connor DL et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. 2001 Pediatrics pmid:11483801
Auestad N et al. Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. 2001 Pediatrics pmid:11483802
Manley BJ et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. 2011 Pediatrics pmid:21708809
Imhoff-Kunsch B et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. 2011 Pediatrics pmid:21807696
Clandinin MT and VanAerde J Formula supplementation and growth. 2003 Pediatrics pmid:14654632
Auestad N et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. 2003 Pediatrics pmid:12949309
D'Vaz N et al. Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial. 2012 Pediatrics pmid:22945403
Isaacs EB et al. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. 2011 Pediatrics pmid:21930549
Henriksen C et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. 2008 Pediatrics pmid:18519483
Makrides M et al. Dietary long-chain polyunsaturated fatty acids do not influence growth of term infants: A randomized clinical trial. 1999 Pediatrics pmid:10469771
Helland IB et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. 2001 Pediatrics pmid:11694666
Murakami K et al. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. 2010 Pediatrics pmid:20713476
Beblo S et al. Effects of alcohol intake during pregnancy on docosahexaenoic acid and arachidonic acid in umbilical cord vessels of black women. 2005 Pediatrics pmid:15687427
Krugman S and Law P Breastfeeding and IQ. 1999 Pediatrics pmid:9988628
Pawlik D et al. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. 2011 Pediatrics pmid:21199856
Bueno AA et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. 2008 Pflugers Arch. pmid:17717684
Jiang LH et al. Oral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat. 2013 Pharm Biol pmid:23767459
Hörcher U [Omega-3-fatty acids from fish oil for the prevention of myocardial infarct]. 1988 Pharm Unserer Zeit pmid:2840674